PMC:7696151 / 81981-82204
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 2387 | 104-107 | Gene | denotes | CA4 | Gene:12351 |
| 2390 | 54-57 | Gene | denotes | CA4 | Gene:12351 |
| 2401 | 218-222 | Species | denotes | mice | Tax:10090 |
| 2426 | 134-137 | Chemical | denotes | HCQ | MESH:D006886 |
| 2452 | 152-157 | Disease | denotes | tumor | MESH:D009369 |
| 2453 | 203-214 | Disease | denotes | lung cancer | MESH:D008175 |
| 2463 | 198-202 | CellLine | denotes | A549 | CVCL:0023 |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T192 | 152-157 | Phenotype | denotes | tumor | http://purl.obolibrary.org/obo/HP_0002664 |
| T193 | 203-214 | Phenotype | denotes | lung cancer | http://purl.obolibrary.org/obo/HP_0100526 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T524 | 0-223 | Sentence | denotes | Likewise, Vayssade, et al. [160] conceived a nanogel (CA4-FeAlg/HCQ) for co-addressing vascular blocker CA4 and anti-autophagic agent HCQ (30 mg/kg) in tumor blood vessels, to synergistically treat A549 lung cancer in mice. |